Companies: 10,795·Total market cap: $144.5T
Augmedix, Inc.

Augmedix, Inc.

AUGXNASDAQHealthcare
$2.35
$-0.01(-0.21%)
Market Cap$115908895
P/E Ratio—
52W High$6.25
52W Low$0.73
SEC Filings

Augmedix, Inc. (AUGX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001769804 · AUGX · NASDAQ · as of Jun 9, 2026

Filing snapshot

392
Total Filings
SC 13G/A
Latest Form
2024-11-13
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001769804 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-04-29
Fiscal Year End
Apr 29, 2024
Accession No.
0001628280-24-018974
Primary Document
augx-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001769804 · Accession 0001628280-24-018974

Latest Key Filings

10-QQuarterly Report
10-Q
2024-08-12
View 10-Q on SEC
8-KCurrent Report
8-K
2024-10-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2024-11-13
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2024-11-13
View
15-12G15-12G
15-12G
2024-10-15
View
SC 13D/ASC 13D/A
SC 13D/A
2024-10-04
View
EFFECTEFFECT
EFFECT
2024-10-03
View
EFFECTEFFECT
EFFECT
2024-10-03
View
EFFECTEFFECT
EFFECT
2024-10-03
View
25-NSE25-NSE
25-NSE
2024-10-02
View
S-8 POSS-8 POS
S-8 POS
2024-10-02
View
S-8 POSS-8 POS
S-8 POS
2024-10-02
View
S-8 POSS-8 POS
S-8 POS
2024-10-02
View
S-8 POSS-8 POS
S-8 POS
2024-10-02
View
POS AMPOS AM
POS AM
2024-10-02
View
POS AMPOS AM
POS AM
2024-10-02
View
POS AMPOS AM
POS AM
2024-10-02
View
Showing 1–15 of 243 filingsForm 4 / 144 hidden· 392 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001769804  |  Exchange: NASDAQ · Healthcare

Augmedix, Inc. (NASDAQ: AUGX) has submitted 392 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001769804, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Augmedix, Inc.'s most comprehensive regulatory disclosure. The most recent Augmedix, Inc. 10-K was filed on 2024-04-29 for fiscal year ending 2024. Historical AUGX 10-K annual reports are available from 2019 through 2024.

Investors researching Augmedix, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TRML SEC Filings →TBRG SEC Filings →DBTX SEC Filings →GRAY SEC Filings →SCTL SEC Filings →OPNT SEC Filings →CYT SEC Filings →PROC SEC Filings →
→ AUGX Financials→ AUGX Earnings→ AUGX Insider Trades

Frequently Asked Questions

AUGX SEC Filings · 8 questions

Augmedix, Inc. (AUGX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 392 filings and access original documents at no cost. Augmedix, Inc.'s CIK is 0001769804.

AUGX SEC filingsAugmedix, Inc. SEC documentsfind AUGX 10-K